Precision nutrition and postprandial immune responses

Acronym

NUTRIOME

Description of the granted funding

A grand challenge for sustainable development in Europe is to improve public health through reducing incidence of non-communicable diseases, premature mortality and health costs. An unhealthy diet is one of the most important risk factors for the global burden of diseases. Therefore, changing the dietary habits in the population is urgently needed. Precision nutrition is an important area for EU's research and innovation policy Food2030 and has emerged as a paradigm with promising results that could help to improve health in the post-genome era. To allow development of more effective preventive strategies via precision nutrition, the determinants driving the inter-personal differences in response to specific foods and meals need to be better understood. This implies also the underlying mechanisms causing differential responses. We eat meals several times per day and are constantly in the postprandial phase. Postprandial changes in circulating metabolites play a major role on human health and the immune response. This leads to the question if one can predict the type of meal, which will be most beneficial to improve an individuals’ metabolic health. Once such knowledge emerges, tailored stratified dietary advice can be developed and evaluated. The focus of NUTRIOME is to train 10 Research Doctoral Candidates (RDCs) in data-driven precision nutrition using two complementary training strategies to learn how to handle and combine multi-omics data, to evaluate the response to foods and diets. We will provide multi-disciplinary training, so that the RDCs: i) are able to utilize, share and disseminate public available multi-omics data, ii) know the regulations and routine for collaborative data sharing in a FAIR manner, and iii) are experts in analyzing, integrating and interpreting increasingly complex data. This will provide a new competence profile to resolve a bottleneck for development of personalised preventive solutions for improved health in Europe.
Show more

Starting year

2023

End year

2027

Granted funding

286 488 €
Participant
Zoe limited (UK)
Participant
CAPITAINER AB (SE)
Participant
Norilia AS (NO)
Participant
MS-OMICS APS (DK)
Participant
NORTURA SA (NO)
Participant
Instytut Rozrodu Zwierzat i Badan Zywnosci Polskiej Akademii Nauk (PL)
226 512 €
Participant
TATAA BIOCENTER AB (SE)
Participant
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE)
286 488 €
Participant
UNIVERSITETET I OSLO (NO)
595 497.6 €
Coordinator
UNIVERSITEIT MAASTRICHT (NL)
274 370.4 €
Participant
CHALMERS TEKNISKA HOEGSKOLA AB (SE)
293 709.6 €
Participant
WAGENINGEN UNIVERSITY (NL)
274 370.4 €
Participant
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (DE)
260 539.2 €
Participant
KOBENHAVNS UNIVERSITET (DK)
301 788 €
Participant

Amount granted

2 799 763 €

Funder

European Union

Funding instrument

HORIZON TMA MSCA Doctoral Networks

Framework programme

Horizon Europe (HORIZON)

Call

Programme part
Marie Skłodowska-Curie Actions (MSCA) (11677)
Topic
MSCA Doctoral Networks 2022 (HORIZON-MSCA-2022-DN-01-01)
Call ID
HORIZON-MSCA-2022-DN-01

Other information

Funding decision number

101119497

Identified topics

public health, occupational health